A citation-based method for searching scientific literature

Lekha Mikkilineni, James N Kochenderfer. Nat Rev Clin Oncol 2021
Times Cited: 73



Justin Eyquem, Jorge Mansilla-Soto, Theodoros Giavridis, Sjoukje J C van der Stegen, Mohamad Hamieh, Kristen M Cunanan, Ashlesha Odak, Mithat Gönen, Michel Sadelain. Nature 2017
Times Cited: 847




List of shared articles



Times cited

Engineering enhanced CAR T-cells for improved cancer therapy.
Michael C Milone, Jie Xu, Sai-Juan Chen, McKensie A Collins, Jianfeng Zhou, Daniel J Powell, J Joseph Melenhorst. Nat Cancer 2021
15


Targeting loss of heterozygosity for cancer-specific immunotherapy.
Michael S Hwang, Brian J Mog, Jacqueline Douglass, Alexander H Pearlman, Emily Han-Chung Hsiue, Suman Paul, Sarah R DiNapoli, Maximilian F Konig, Drew M Pardoll, Sandra B Gabelli,[...]. Proc Natl Acad Sci U S A 2021
16

Nanobody-armed T cells endow CAR-T cells with cytotoxicity against lymphoma cells.
Hongxia Wang, Liyan Wang, Yanning Li, Guangqi Li, Xiaochun Zhang, Dan Jiang, Yanting Zhang, Liyuan Liu, Yuankui Chu, Guangxian Xu. Cancer Cell Int 2021
3

In-Vivo Induced CAR-T Cell for the Potential Breakthrough to Overcome the Barriers of Current CAR-T Cell Therapy.
Tianqing Xin, Li Cheng, Chuchao Zhou, Yimeng Zhao, Zhenhua Hu, Xiaoyan Wu. Front Oncol 2022
1

Next-Generation CAR T-cell Therapies.
Regina M Young, Nils W Engel, Ugur Uslu, Nils Wellhausen, Carl H June. Cancer Discov 2022
2

BCMA-targeted therapies for multiple myeloma: strategies to maximize efficacy and minimize adverse events.
Edmund Watson, Faouzi Djebbari, Alexandros Rampotas, Karthik Ramasamy. Expert Rev Hematol 2022
0